MI’s Neuroradiology Division held its annual Neuroradiology Research Day at University of Toronto’s Hart House on May 26, 2026, taking place from 5:45 – 9:50 p.m.
The night opened with a welcome address from MI Associate Professor & Neuroradiology Program Director Dr. Helen Branson before a buffet dinner was served for attendees. The rest of the evening included 12 trainee presentations with a coffee break in between and closed with a final address from Dr. Branson.
Thank you to the presenters, attendees, and everyone who helped put this event together.
See presenting fellows and the titles of their presentations below:
Dr. Cristina Arizaga: 3D Segmented EPI T2*-W GE for Swallow Tail Sign assessment in Parkinsonian disorders
Dr. Margarita Beltran: Bening Rounded Cerebellar Lesions of the cerebellum
Dr. Bo Gong: Fusion Strategies and Performance–Efficiency Trade-offs in Brain MRI Deep Learning Detection of Focal Cortical Dysplasia
Dr. Rayyan Kinsara: Largest Canadian Experience with Transvenous Embolization of CSF-Venous Fistulas: Techniques, Clinical Pathway and Outcomes
Dr. James Lord: Performance of AI Software in Acute Ischemic Stroke: Sensitivity for LVO Detection, ASPECTS Evaluation, and Association with Vessel Density
Dr. Benjamin Morgan: Lesion network mapping and cognitive function in neurodegenerative LCH
Dr. Disha Patel: CT Prevalence of Superior Semicircular Canal Dehiscence in Emergency Department Patients With and Without Vertigo
Dr. Paul Ryan: Perineural Tumour Spread in the Head and Neck - An Educational Tool
Dr. Eliana Sacher: Gadolinium-Based Contrast Agents in the Follow-up of Pituitary Adenomas Following Transsphenoidal Surgery: Are Clinical Outcomes Affected?
Dr. Hang Yu: Optimal Virtual Monoenergetic Energy Level in Dual-Energy CT for Assessing Intracranial Arteries after Flow Diverter Treatment of Intracranial Aneurysms
Dr. Eleyine Zarour: Distinguishing Brain Metastases Radiation Necrosis from Tumor Progression Using Radiological Signs and Naive Bayesian Analysis
Dr. Sahar Abbasi: MRI Assessment of Brain Metastases in EGFR-Positive NSCLC Before and After Osimertinib Treatment